These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 46683)

  • 21. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Postovulatory effect of gestagens].
    Johansson ED; Nygren KG
    Nord Med; 1971 Aug; 86(33):988. PubMed ID: 4106202
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gestation time prolonging effect of progesterone and various synthetic gestagens in the rat].
    Bührdel P; Willgerodt H; Theile H
    Acta Biol Med Ger; 1974; 32(2-3):193-8. PubMed ID: 4138839
    [No Abstract]   [Full Text] [Related]  

  • 26. Luteolytic effect of gestagens.
    Johansson ED
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:75. PubMed ID: 4107701
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
    Lähteenmäki P
    Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats.
    Doyle LL
    Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal progesterone for contraception.
    Victor A; Jackanicz TM; Johansson ED
    Fertil Steril; 1978 Dec; 30(6):631-5. PubMed ID: 729823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Menstrual induction" with Sulproston.
    Csapo AI; Peskin EG; Pulkkinen M; Laajoki V; Kivikoski A; Lampe L; Godeny S; Szeverenyi M; Herczeg J; Resch B; Bacos L
    Prostaglandins; 1982 Nov; 24(5):657-665. PubMed ID: 6298903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the abortifacient effect of oxymetholone in early gestation.
    Brenner PF; Mishell DR
    Contraception; 1975 Jun; 11(6):669-76. PubMed ID: 1137938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Termination of early gestation with vaginal prostaglandin F2 alpha tablets.
    Corlett RC; Sribyatta B; Mishell DR; Ballard C; Nakamura RM; Thorneycroft IH
    Prostaglandins; 1972 Dec; 2(6):453-64. PubMed ID: 4666665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.